Hemant R. Jadhav
Pilani, RJ, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 43 publications
From bench chemistry to clinical candidates: pharmacological profiles, position-specific SARs, and patent landscape of pyridone derivatives (2014-2025).
Journal: RSC medicinal chemistry
Published: June 02, 2026
Histone demethylase inhibitors: developmental insights and current status.
Journal: Future medicinal chemistry
Published: August 19, 2025
Emerging in Diabetic Cardiomyopathy: Molecular Pathways and Targets for Therapeutic Intervention.
Journal: Drug development research
Published: July 23, 2025
Corrigendum to "Design and development of chromene-3-carboxylate derivatives as antidiabetic agents: Exploring the antidiabetic potential via dual inhibition of angiotensin II type 1 receptor and neprilysin enzyme" [Europ. J. Med. Chem. 293 (2025) 117705].
Journal: European journal of medicinal chemistry
Published: June 17, 2025
A Novel Combination of Exogenous Klotho Combined With Telmisartan Ameliorated Diabetic Cardiomyopathy via an Antifibrotic Mechanism.
Journal: Cell biology international
Published: June 07, 2025
Design and development of chromene-3-carboxylate derivatives as antidiabetic agents: Exploring the antidiabetic potential via dual inhibition of angiotensin II type 1 receptor and neprilysin enzyme.
Journal: European journal of medicinal chemistry
Published: January 20, 2025
Unfolding the Potential of Pyrrole- and Indole-Based Allylidene Hydrazine Carboximidamides as Antimicrobial Agents.
Journal: ACS infectious diseases
Published: January 13, 2025
Structure-based virtual screening of FDA-approved drugs to discover potential inhibitors of phosphoinositide kinase, PIKfyve.
Journal: Journal of biomolecular structure & dynamics
Published: December 11, 2024
Novel therapeutic targets for cardiorenal syndrome.
Journal: Drug discovery today
Published: November 02, 2024
Recent advancements in the therapeutic approaches for Alzheimer's disease treatment: current and future perspective.
Journal: RSC medicinal chemistry
Published: August 16, 2024
A perspective on the development of small molecular neprilysin inhibitors (NEPi) with emphasis on cardiorenal disease.
Journal: European journal of medicinal chemistry
Published: June 24, 2024
Last Updated: 09/26/2026